Sanjiv Patel biography

Sanjiv K. (Sanj) Patel is Chairman of the Board, Chief Executive Officer of the Company. In June 2008, Mr. Patel formed Synageva, a biotechnology company focused on rare diseases, where he served as President and Chief Executive Officer and was a member of its board of directors until Synageva's sale to Alexion Pharmaceuticals, Inc. ("Alexion"), in June 2015. Prior to Synageva, Mr. Patel held various roles at Genzyme Corporation ("Genzyme") from 1999 to 2008, most recently as head of U.S. Sales, Marketing and Commercial Operations for the Genzyme Therapeutics franchise. Mr. Patel previously served as a member of the boards of directors of Syros Pharmaceuticals, Inc., BioCryst Pharmaceuticals, Inc., and Intercept Pharmaceuticals, Inc. He is also the founder and director of the Sanj K. Patel and Family Foundation, a philanthropic organization that supports charities for patients with rare and devastating diseases. Mr. Patel holds a B.Sc. with Honors from the University of the South Bank, London and completed his management and business studies at Ealing College, London and his Pharmacology research program at the Wellcome Foundation.

What is the salary of Sanjiv Patel?

As the Chairman of the Board and Chief Executive Officer of Kiniksa Pharmaceuticals Ltd, the total compensation of Sanjiv Patel at Kiniksa Pharmaceuticals Ltd is $4,765,670. There are no executives at Kiniksa Pharmaceuticals Ltd getting paid more.